← All Sponsors
SPONSOR

Oana Danciu

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Locoregional RecurrenceHormone Receptor-positive Breast CancerHER2-negative Breast Cancer
NCT05467891 Phase 2
Recruiting

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

Locoregional Recurrence
United States View Trial →